Current status of the clinical use of PD-1/PD-L1 inhibitors: a questionnaire survey of oncologists in China.
Bicheng ZhangYuxiao SongYang FuBo ZhuBaocheng WangJun WangPublished in: BMC cancer (2020)
The present study highlights the current status of PD-1/PD-L1 inhibitors in China. Increasing numbers of medical oncologists are interested in PD-1/PD-L1 inhibitors, and they are in need of immunotherapy education.